Preterm premature rupture of membranes is an important cause of preterm delivery. Management includes antibiotic therapy and a course of steroids. Current approach is to give two doses of steroid betamethasone 24 hours apart. We recruited 100 women with pPROM between 26-34 weeks period of gestation, divided into two groups of 50 each, receiving betamethasone two doses either 12 hours or 24 hours apart. Aim was to see difference in outcome of Respiratory distress syndrome (RDS) and other morbidities like intraventricular heamorrhage (IVH), necrotizing enterocolitis (NEC) and Neonatal sepsis. We found no statistical difference in the outcome of RDS and other morbidities except birth asphyxia. We concluded that women with Pprom can be offered course of steroids with 12 hour interval. Moreover it had the advantage of having more women completing the course of steroids before delivery.
Introduction
Preterm premature rupture of membranes (pPROM) is an important cause of premature delivery. Although exact etiology of pPROM is unknown but various risk factors associated are: Black race, 1 low socioeconomic status, smoking, history of sexually transmitted infections, preterm delivery and uterine distension (e.g., polyhydramnios, multifetal pregnancy). 2 pPROM is strongly associated with maternal infectious morbidity like chorioamnionitis, endometritis and bacteremia. Management of women with pPROM requires an assessment of benefits and risks of continuing pregnancy vs immediate delivery. It complicates only 2% pregnancies but is associated with 40% of preterm deliveries. 3 When membranes rupture between 28-34 weeks, 50%women go into labour within 24 hours and 80-90%within one week. 4 The currently accepted approach is based on expectant management between 24 to 32weeks of gestation in combination with adjunctive antibiotic therapy and a course of steroids. http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i8.112
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The most common cause of deaths among preterm birth is respiratory distress syndrome (RDS), others being necrotising enterocolitis (NEC), intraventricular haemorrhage (IVH), chronic lung disease (CLD), neonatal sepsis. Research has shown that glucocorticoid administration has a significant beneficial effect for preterm births as it decreases the incidence of respiratory distress syndrome in infants delivered between 26 &34 weeks of gestation, also reduces the incidence of intraventricular haemorrhage, improves circulatory stability, reduces the need for oxygen & ventilator support and reduces overall neonatal mortality. Currently the National Institute Of Health recommended 2 doses of 12mg of betamethasone (BTM) intramuscular 24 hours apart while total doses was based on efficacy found on animal studies. The NIH admits 2 doses regimen was chosen arbitrarily and has recognised as an urgent need for studies on dosing interval variations. 2, 5 25-40% of women at risk for preterm delivery deliver within 24 hours prior to receiving complete course of steroids. Only 5% of these deliver within 12 hours. 6 If 24 hours dosing schedule is followed several women may miss to receive the second dose and will go into preterm labour and deprived of its benefits. So the present study is undertaken to compare the efficacy of the two dosing schedules in reducing the incidence of respiratory distress syndrome in preterm neonate born to mother with pPROM.
Aims and Objectives
To determine whether there is difference in the incidence of RDS (Respiratory distress syndrome) in neonates when administrating 2 doses of betamethasone 12mg intramuscular 12hours vs. 24 hours apart in preterm premature rupture of membranes.
Methodology
This randomised study was conducted in Clean Labour Room & Antenatal OPD of Department of Obstetrics and Gynaecology of Postgraduate Institute of Medical Education and Research, Chandigarh. A total of 100 women with preterm premature rupture of membranes (pPROM) between 26 to 34 weeks period of gestation were recruited for this study after assessing their eligibility criteria. Pregnant women with period of gestation less than 26 weeks or more than 34 weeks, women having received steroids other than betamethasone, congenital malformation in fetus, intrauterine fetal death and women having features of chorioamnionitis were excluded from the study. After inclusion criteria were fulfilled, written informed consent was taken from all women prior to recruitment for this study. Detailed history was recorded on pre designed performa which was followed by general physical and obstetric examination. Obstetric sonography was done to assess fetal biometry, amniotic fluid along with fetal biophysical profile. Non stress test was also performed for complete assessment of fetal wellbeing. Screening for major congenital anomalies was done in case it had not been done during routine sonography between 16 to 20 weeks. A speculum examination was performed under all aseptic conditions and swabs were taken from cervix for bacterial culture and sensitivity testing. Haematological tests including haemoglobin, TLC, DLC, and urine analysis (routine and culture) were done at admission. Intravenous Ampicillin 2 gm every 6 hrs for 48 hours followed by oral amoxicillin 500mg every 8 hours for 5 days and oral Erythromycin 250mg were given every 6 hourly for 7 days starting from the time of admission. After the diagnosis of pPROM was confirmed based on history, clinical examination or on ultrasonography then according to randomisation patient was given injection betamethasone in two doses either 12 hours apart or 24 hours apart. If patient was on conservative management and shifted toward details of cervical swabs sent for culture were noted and monitoring was done till the women went into labour either spontaneously or after induction. Patients were monitored daily for the signs and symptoms of 
Approval by the Research and Ethics Committee
The protocol was approved by institute's Ethical Committee and guidelines set up by ICMR (1994), and Helsinki Declaration (modified 2000) was adhered in all patients enrolled in the study. Table 1 shows the distribution of women according to the period of gestation at the time of pPROM. The mean gestational age was 31 3/7 weeks in group A and 30 2/7 weeks in group B at the time of pPROM. The women in the group A had higher mean gestational age at the time of pPROM than in group B (p=0.067) but the difference was not clinically significant, hence the women in two groups were matched according to period of gestation at time of Pprom. Table 2 shows the number of doses either single or both received by the women in the two groups.
Results
In total 15 patients out of 100 went into spontaneous labour and delivered before receiving the second dose. These women were more in group B. However the difference was not found to be significant. Table 3 shows the mode of delivery in the two groups. More patients in the group B delivered vaginally but the difference however was not found to be statistically significant. Of the women in the group A, 36(73.5%) out of 49 had vaginal delivery. One woman delivered outside PGIMER. Two (4.1%) out of 36 needed forceps delivery in view of fetal bradycardia. Thirteen underwent caesarean section. Emergency caesarean was done in 12(24.5%) out of 13 and 1(2.2%) patient had undergone elective caesarean. In the group B, 41(82%) out of 50 had vaginal delivery and 9(18%) out of 50 had undergone emergency caesarean section. One patient of the 41 in group B who had a vaginal delivery had a forceps delivery. The overall mean birth weights in the group A was 1735.60±392.67 grams, and in the group B was 1588.34±409.34 grams. The difference in the two groups was not statistically significant. Table 6 shows the incidence of neonatal complications in the two groups. Birth asphyxia was more in group B which was found to be clicnically significant. In others respiratory distress syndrome was more in group B. Rest of the complications including Neonatal Jaundice, Neonatal Sepsis and Intraventricular Heammorhage were more in group A but the difference was not found to be clinically significant. 
Discussion
The present study was planned to assess the effect of giving two doses of Betamethasone either 12 hours or 24hours apart on the maternal and neonatal outcomes in women with preterm premature rupture of membranes. Patients were divided after randomization into two groups of 50 women in each and were given Inj. 
Conclusion
The data and the results from the study suggest that the maternal as well as neonatal outcomes were similar in the 12 hours and 24 hours group except birth asphyxia which was seen more in group B i.e. the 24 hours group with statistically significant difference. Rest of the variables were almost similar in the two groups. Thus it seems to suggest that 12 hour dosing interval is equally beneficial as 24 hours and can be offered to the patients. One advantage of 12 hours dosing interval is that it can result in more number of patients completing the course of steroids before delivery compared to the conventional 24 hours dosage schedule. Hence we can conclude that 12 hours dosage schedule can be offered to the women but studies at large scale are required to validate this approach.
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